Helen I. Field
Molecular Biology · 2008–2013
A researcher in the Science corpus: 14 papers; trusts 5 researchers and is trusted by 15 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 122 citations into it; #2,165 of 17,773 by trust here, #1,910 by citations
Whom Helen I. Field trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Helen I. Field overall
Papers from Helen I. Field's perspective
Ordered by how strongly the researchers Helen I. Field trusts endorse each paper. Same corpus, a different order for every researcher.
- Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins (Nature)
- Histone methylation in transcriptional control. (Current Opinion in Genetics and Development)
- Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain (Nature)
- The language of covalent histone modifications (Nature)
- Regulation of chromatin structure by site-specific histone H3 methyltransferases (Nature)
- Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. (Cell)
- SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells
- SET Domain-containing Protein, G9a, Is a Novel Lysine-preferring Mammalian Histone Methyltransferase with Hyperactivity and Specific Selectivity to Lysines 9 and 27 of Histone H3* (Journal of Biological Chemistry)
- MLL translocations, histone modifications and leukaemia stem-cell development (Nature Reviews. Cancer)
- Genome-wide map of nucleosome acetylation and methylation in yeast. (Cell)
Their papers
- Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers (2011) — 455 citations
- Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers (2011) — 318 citations
- Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker (2011) — 190 citations
- Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway (2010) — 222 citations
- Abstract 3019: Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells (2011) — 207 citations
- Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer (2011) — 114 citations
- Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1. (2011) — 120 citations
- Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression. (2012) — 179 citations
- Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase B (2012) — 120 citations
- Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway. (2011) — 100 citations
- The Histone Demethylase JMJD2B Plays an Essential Role in Human Carcinogenesis through Positive Regulation of Cyclin-Dependent Kinase 6 (2011) — 68 citations
- The histone methyltransferase Wolf–Hirschhorn syndrome candidate 1‐like 1 (WHSC1L1) is involved in human carcinogenesis (2013) — 67 citations
- The JmjC domain‐containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene (2012) — 96 citations
- Multiple newly identified loci associated with prostate cancer susceptibility (2008) — 884 citations